CRRL 101, A Novel Bispecific Biologic Targeting The Glucagon-like Peptide-1 (glp-1) Receptor And Guanylyl Cyclase A (gca) Receptor, Demonstrates Beneficial Cardiometabolic Effects In Vitro

Journal of Cardiac Failure 2026

View at publisher

Authors: Jasraj Singh, Fadi Adel, Xiaoyu Ma, Ye Zheng, Shuchong Pan, JC Malsawmzuali, Dante G. Moroni, Horng Chen

DOI: 10.1016/j.cardfail.2025.11.005

Cited by: 1

Fields of Study & Subjects

Diabetes Treatment and Management Neuropeptides and Animal Physiology Heart Failure Treatment and Management